Welcome!

News Feed Item

Diarrhea Global Clinical Trials Review, H1, 2013

NEW YORK, May 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Diarrhea Global Clinical Trials Review, H1, 2013
http://www.reportlinker.com/p0829678/Diarrhea-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Diarrhea Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, "Diarrhea Global Clinical Trials Review, H1, 2013" provides data on the Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diarrhea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diarrhea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Diarrhea 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Diarrhea 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Diarrhea Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Sanofi 34
Clinical Trial Overview of Sanofi 34
Optimer Pharmaceuticals, Inc. 35
Clinical Trial Overview of Optimer Pharmaceuticals, Inc. 35
Salix Pharmaceuticals, Inc. 36
Clinical Trial Overview of Salix Pharmaceuticals, Inc. 36
Romark Laboratories, L.C. 37
Clinical Trial Overview of Romark Laboratories, L.C. 37
Johnson & Johnson 38
Clinical Trial Overview of Johnson & Johnson 38
Intercell AG 39
Clinical Trial Overview of Intercell AG 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Ipsen S.A. 41
Clinical Trial Overview of Ipsen S.A. 41
Glenmark Pharmaceuticals Ltd. 42
Clinical Trial Overview of Glenmark Pharmaceuticals Ltd. 42
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Mead Johnson Nutrition Company 44
Clinical Trial Overview of Mead Johnson Nutrition Company 44
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
AGI Therapeutics plc 46
Clinical Trial Overview of AGI Therapeutics plc 46
NIZO food research BV 47
Clinical Trial Overview of NIZO food research BV 47
Ventria Bioscience 48
Clinical Trial Overview of Ventria Bioscience 48
Bio-K+ International Inc. 49
Clinical Trial Overview of Bio-K+ International Inc. 49
Furiex Pharmaceuticals, Inc. 50
Clinical Trial Overview of Furiex Pharmaceuticals, Inc. 50
Friesland Coberco Dairy Foods Holding N.V. 51
Clinical Trial Overview of Friesland Coberco Dairy Foods Holding N.V. 51
Genzyme Corporation 52
Clinical Trial Overview of Genzyme Corporation 52
Nestle SA 53
Clinical Trial Overview of Nestle SA 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
ICDDR,B 54
Clinical Trial Overview of ICDDR,B 54
U.S. Centers for Disease Control and Prevention 55
Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 55
International Vaccine Institute 56
Clinical Trial Overview of International Vaccine Institute 56
The University of Nottingham 57
Clinical Trial Overview of The University of Nottingham 57
The Johns Hopkins Bloomberg School of Public Health 58
Clinical Trial Overview of The Johns Hopkins Bloomberg School of Public Health 58
Aga Khan University 59
Clinical Trial Overview of Aga Khan University 59
Centro Pediatrico Albina de Patino 60
Clinical Trial Overview of Centro Pediatrico Albina de Patino 60
Johns Hopkins University 61
Clinical Trial Overview of Johns Hopkins University 61
University of Virginia 62
Clinical Trial Overview of University of Virginia 62
Mayo Clinic 63
Clinical Trial Overview of Mayo Clinic 63
Christian Medical College 64
Clinical Trial Overview of Christian Medical College 64
University of Pittsburgh 65
Clinical Trial Overview of University of Pittsburgh 65
Seoul National University Hospital 66
Clinical Trial Overview of Seoul National University Hospital 66
London School of Hygiene & Tropical Medicine 67
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 67
Shanghai University of Traditional Chinese Medicine 68
Clinical Trial Overview of Shanghai University of Traditional Chinese Medicine 68
Centre for International Health 69
Clinical Trial Overview of Centre for International Health 69
The University of Texas Health Science Center at Houston 70
Clinical Trial Overview of The University of Texas Health Science Center at Houston 70
John D. Dingell VA Medical Center 71
Clinical Trial Overview of John D. Dingell VA Medical Center 71
Medical University of Warsaw 72
Clinical Trial Overview of Medical University of Warsaw 72
Hadassah Medical Organization 73
Clinical Trial Overview of Hadassah Medical Organization 73
Five Key Clinical Profiles 74
Appendix 123
Abbreviations 123
Definitions 123
Research Methodology 124
Secondary Research 124
About GlobalData 125
Contact Us 125
Disclaimer 125
Source 126

List of Tables

Diarrhea Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Diarrhea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Diarrhea Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Diarrhea Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Diarrhea Therapeutics Clinical Trials, G7 Countries, 2013* 17
Diarrhea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Diarrhea Therapeutics Clinical Trials, E7 Countries, 2013* 19
Diarrhea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Diarrhea Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Diarrhea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Diarrhea Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Diarrhea Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Diarrhea Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Diarrhea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 34
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Optimer Pharmaceuticals, Inc., 2013* 35
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals, Inc., 2013* 36
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Romark Laboratories, L.C., 2013* 37
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 38
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Intercell AG, 2013* 39
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 40
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2013* 41
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Glenmark Pharmaceuticals Ltd., 2013* 42
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 43
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mead Johnson Nutrition Company, 2013* 44
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 45
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by AGI Therapeutics plc, 2013* 46
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by NIZO food research BV, 2013* 47
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Ventria Bioscience, 2013* 48
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-K+ International Inc., 2013* 49
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Furiex Pharmaceuticals, Inc., 2013* 50
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Friesland Coberco Dairy Foods Holding N.V., 2013* 51
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2013* 52
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle SA, 2013* 53
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by ICDDR,B, 2013* 54
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Centers for Disease Control and Prevention, 2013* 55
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by International Vaccine Institute, 2013* 56
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Nottingham, 2013* 57
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins Bloomberg School of Public Health, 2013* 58
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2013* 59
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Centro Pediatrico Albina de Patino, 2013* 60
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 61
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2013* 62
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 63
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, 2013* 64
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 65
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 66
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2013* 67
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai University of Traditional Chinese Medicine, 2013* 68
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for International Health, 2013* 69
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2013* 70
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by John D. Dingell VA Medical Center, 2013* 71
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Warsaw, 2013* 72
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 73

List of Figures

Diarrhea Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Diarrhea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Diarrhea Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Diarrhea Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Diarrhea Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Diarrhea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Diarrhea Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Diarrhea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Diarrhea Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Diarrhea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Diarrhea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
GlobalData Methodology 124

To order this report:
Drug_Discovery_and_Development Industry:
Diarrhea Global Clinical Trials Review, H1, 2013

__________________________
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
SYS-CON Events announced today that NetApp has been named “Bronze Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. NetApp is the data authority for hybrid cloud. NetApp provides a full range of hybrid cloud data services that simplify management of applications and data across cloud and on-premises environments to accelerate digital transformation. Together with their partners, NetApp em...
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new technologies can require relearning or adapting new, oftentimes more complex, methodologies and tools to be ready for production. In his general session at @DevOpsSummit at 20th Cloud Expo, Chris Brown, Solutions Marketi...
SYS-CON Events announced today that SIGMA Corporation will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. uLaser flow inspection device from the Japanese top share to Global Standard! Then, make the best use of data to flip to next page. For more information, visit http://www.sigma-k.co.jp/en/.
Most of the time there is a lot of work involved to move to the cloud, and most of that isn't really related to AWS or Azure or Google Cloud. Before we talk about public cloud vendors and DevOps tools, there are usually several technical and non-technical challenges that are connected to it and that every company needs to solve to move to the cloud. In his session at 21st Cloud Expo, Stefano Bellasio, CEO and founder of Cloud Academy Inc., will discuss what the tools, disciplines, and cultural...
Why Federal cloud? What is in Federal Clouds and integrations? This session will identify the process and the FedRAMP initiative. But is it sufficient? What is the remedy for keeping abreast of cutting-edge technology? In his session at 21st Cloud Expo, Rasananda Behera will examine the proposed solutions: Private or public or hybrid cloud Responsible governing bodies How can we accomplish?
SYS-CON Events announced today that N3N will exhibit at SYS-CON's @ThingsExpo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. N3N’s solutions increase the effectiveness of operations and control centers, increase the value of IoT investments, and facilitate real-time operational decision making. N3N enables operations teams with a four dimensional digital “big board” that consolidates real-time live video feeds alongside IoT sensor data a...
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
Real IoT production deployments running at scale are collecting sensor data from hundreds / thousands / millions of devices. The goal is to take business-critical actions on the real-time data and find insights from stored datasets. In his session at @ThingsExpo, John Walicki, Watson IoT Developer Advocate at IBM Cloud, will provide a fast-paced developer journey that follows the IoT sensor data from generation, to edge gateway, to edge analytics, to encryption, to the IBM Bluemix cloud, to Wa...
There is huge complexity in implementing a successful digital business that requires efficient on-premise and cloud back-end infrastructure, IT and Internet of Things (IoT) data, analytics, Machine Learning, Artificial Intelligence (AI) and Digital Applications. In the data center alone, there are physical and virtual infrastructures, multiple operating systems, multiple applications and new and emerging business and technological paradigms such as cloud computing and XaaS. And then there are pe...
With the rise of DevOps, containers are at the brink of becoming a pervasive technology in Enterprise IT to accelerate application delivery for the business. When it comes to adopting containers in the enterprise, security is the highest adoption barrier. Is your organization ready to address the security risks with containers for your DevOps environment? In his session at @DevOpsSummit at 21st Cloud Expo, Chris Van Tuin, Chief Technologist, NA West at Red Hat, will discuss: The top security r...
SYS-CON Events announced today that B2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. B2Cloud specializes in IoT devices for preventive and predictive maintenance in any kind of equipment retrieving data like Energy consumption, working time, temperature, humidity, pressure, etc.
DevOps at Cloud Expo – being held October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real r...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
Your clients expect transactions to never fail, cloud access to be fast and always on, and their data to be protected - no exceptions. Hear about how Secure Service Container (SSC), an IBM-exclusive open technology, enables secure building and hosting of next-generation applications, both cloud and on-premises. SSC protects the full stack from external and insider threats, allows automatic encryption of data in-flight and at-rest, and is tamper-resistant during installation and runtime – with no...